Article content

IMDZ chart

Immune Design ASH Data Release Play

Immune Design will report Phase 2 long-term follow up combo data due at ASH December 2, 2018 at 6:00PM for G100 for follicular non-Hodgkin Lymphoma. The company has a slide presentation here.

IMDZ Stock

IMDZ chart

That’s a powerful move off the bottom ahead of the ASH event this Sunday evening on December 2, 2018.

Disclosure: I am long IMDZ stock.

Immune Design News

Picture of SOFI artificial intelligence

SOFI AI For Premium Members